|
⚲
|
| Keyboard |
| Burrill Life Sciences Capital Fund III L P
✚
|
|
|---|---|
| CIK # | 0001353885 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001353885] | |
| 4 | [0001353885] | |
| SC 13D | [0001353885] | |
| SC 13G | [0001353885] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Dalal Anupam | |
| Burrill Life Sciences Capital Fund III L P | |
| Kearny Venture Assoicates II LLC | |
| Castelein Caley | |
| Neos Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Neos Therapeutics Inc NEOS
Common Stock
|
2015-07-28 | Conversion | 472,897 | ||
|
Neos Therapeutics Inc NEOS
Common Stock
|
2015-07-28 | Conversion | 561,938 | ||
|
Neos Therapeutics Inc NEOS
Common Stock
|
2015-07-28 | Conversion | 180,217 | ||
|
Neos Therapeutics Inc NEOS
Series C Preferred Stock · derivative
|
2015-07-28 | Conversion | 1,348,655 | ||
|
Neos Therapeutics Inc NEOS
Series B-1 Preferred Stock · derivative
|
2015-07-28 | Conversion | 1,134,954 | ||
|
Neos Therapeutics Inc NEOS
Series B Preferred Stock · derivative
|
2015-07-28 | Conversion | 432,523 |